Key result
Known CAD links to ~6-fold higher 30-day major cardiovascular events despite ESC 0/1-hour algorithm rule-out.
Why the study?
Data comparing NSTEMI rule-out rates and 30-day adverse outcomes using the ESC 0/1-hour high-sensitivity troponin algorithm in emergency department patients with versus without known CAD are limited.
Does the presence of known coronary artery disease affect NSTEMI rule-out rates and 30-day MACE in emergency department patients evaluated with the ESC 0/1-hour hs-cTnT algorithm?
Cohort (n=1,430)
Yes
Does the presence of known coronary artery disease affect NSTEMI rule-out rates and 30-day MACE in emergency department patients evaluated with the ESC 0/1-hour hs-cTnT algorithm?
Patients with known CAD who are rapidly ruled out for NSTEMI via the ESC 0/1-hour hs-cTnT algorithm still face a 7.9% 30-day MACE rate, indicating a need for further cardiac reevaluation despite rule-out status.
Answers are grounded in this paper and cite their sources.
Caution warranted ruling out NSTEMI in known CAD; leaves open whether algorithm modifications improve outcomes in this subgroup.
Background The European Society of Cardiology (ESC) 0/1-hour high sensitivity troponin (hs-cTn) algorithm is widely used in the evaluation of patients presenting to the Emergency Department (ED) with symptoms suspicious for non ST-segment elevation myocardial infarction (NSTEMI). There is limited data available for the use of this algorithm comparing NSTEMI rule-out rates and 30-day adverse outcomes in patients with and without known coronary artery disease (CA), defined as prior myocardial infarction [MI], coronary revascularization, or ≥70% coronary stenosis. Purpose The objective of this secondary analysis of the STOP-CP (High Sensitivity Cardiac Troponin T to Optimize Chest Pain Risk Stratification) United States (US) multicenter study was to compare the ESC 0/1-hour algorithm for rapid NSTEMI rule-out and 30-day adverse outcomes in patients with and without known CAD. Methods Patients (≥21 years old) presenting to the (ED) with symptoms suggestive of NSTEMI were enrolled (1/25/2017–9/6/2018) at 8 US medical centers. The ESC hs-cTnT 0/1-hour hs-cTnT algorithm was used to stratify patients into rule-out, observe, and rule-in zones. Algorithm performance for 30-day adverse outcomes was analyzed in patients with or without known CAD. Major adverse cardiovascular events (MACE) consisted of cardiac death, MI, or coronary revascularization. Fisher's exact tests were used to compare NSTEMI rule-out and 30-day MACE rates in patients with and without known CAD. Negative likelihood ratios (NLR) with a 95% confidence interval (CI) were calculated for 30-day MACE. Results Overall 1430 patients were enrolled. Of these 31.4% (449/1430) had known CAD while 14.2% (203 /1430) experienced 30-day MACE. Using the ESC 0/1-hour hs-cTnT algorithm 39.6% (178/449) of patients with known CAD were placed in the rule-out zone compared to 66.1% (648/981) without CAD (p<0.0001). Of patients with known CAD 23.2% (104/449) had 30-day MACE compared to 10.1% (99/981) of those without known CAD (p<0.0001). Additionally, amongst those patients placed in the rule-out zone, 30-day MACE occurred in 7.9% (14/178) of individuals with known CAD and 1.4% (9/648) of those without known CAD (p<0.0001). NLR for 30-day MACE was 0.28 (95% CI 0.17–0.47) in patients with known CAD and 0.13 (95% CI 0.07–0.23) in those without CAD. Conclusions In the multicenter US STOP-CP study patients with known CAD were less often rapidly ruled out for NSTEMI and had higher 30-day MACE rates than those without known CAD. Patients with known CAD who were rapidly ruled out for NSTEMI had a higher 30-day MACE rate compared to those without known CAD. Our analysis suggests that patients with known CAD require further cardiac reevaluations whether they are ruled out for NSTEMI by the ESC 0/1 hour hs-cTnT algorithm or not. Funding Acknowledgement Type of funding sources: Private company. Main funding source(s): Roche, Basel, Switzerland
No takes yet. Share an insight, caveat, or question.
Nowak et al. (2022) conducted a cohort in Emergency department patients with symptoms suggestive of non ST-segment elevation myocardial infarction (NSTEMI) (n=1,430). Known coronary artery disease (prior MI, coronary revascularization, or ≥70% coronary stenosis) in patients evaluated by the ESC 0/1-hour hs-cTnT algorithm vs. Patients without known coronary artery disease evaluated by the ESC 0/1-hour hs-cTnT algorithm was evaluated on 30-day major adverse cardiovascular events (MACE: cardiac death, MI, or coronary revascularization) among patients placed in the ESC 0/1-hour hs-cTnT rule-out zone (NLR 0.28 (known CAD) vs 0.13 (no CAD), 95% CI 0.17-0.47, p=<0.0001). Known CAD in patients ruled out by the ESC 0/1-hour hs-cTnT algorithm was associated with higher 30-day major cardiovascular events compared to no known CAD.
Synapse has enriched 10 related papers. Consider them for comparative context: